Search General Info
Search Education
Search Partnering Companies

Michael Cardone

Cambridge, Massachusetts, United States
Michael Cardone is the CEO and co-Founder of Eutropics. He leads the company’s efforts to achieve scientific and corporate milestones. His experience includes over 20 years of scientific and business management at early to mid-stage biotech companies. Prior to Eutropics, he was a scientific co-founder of Merrimack Pharmaceuticals, a Cambridge, MA-based company (NASDQ trading symbol: MACK) where he worked with the starting team to develop the oncology program. Prior to this, he led a research team in the Department of Biology at MIT developing tools for small molecule drug target identification and validation. Dr. Cardone received a Ph.D. in protein trafficking from the University of California San Francisco and completed post-doctoral studies in apoptosis signaling at the Burnham Institute in La Jolla, CA
Speaking In
[On Demand]

Eutropics Pharmaceuticals is a biomarker discovery, CLIA laboratory. We develop novel functional…